These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30112081)

  • 21. Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety.
    Palmucci J; Marchetti F; Pettinari R; Pettinari C; Scopelliti R; Riedel T; Therrien B; Galindo A; Dyson PJ
    Inorg Chem; 2016 Nov; 55(22):11770-11781. PubMed ID: 27934319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
    Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
    J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
    Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
    Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex.
    Barragán F; López-Senín P; Salassa L; Betanzos-Lara S; Habtemariam A; Moreno V; Sadler PJ; Marchán V
    J Am Chem Soc; 2011 Sep; 133(35):14098-108. PubMed ID: 21797210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ruthenium(II) complexes of saccharin with dipyridoquinoxaline and dipyridophenazine: Structures, biological interactions and photoinduced DNA damage activity.
    Kumar P; Dasari S; Patra AK
    Eur J Med Chem; 2017 Aug; 136():52-62. PubMed ID: 28482217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives of ruthenium(ii) polyazaaromatic photo-oxidizing complexes photoreactive towards tryptophan-containing peptides and derivatives.
    Estalayo-Adrián S; Garnir K; Moucheron C
    Chem Commun (Camb); 2018 Jan; 54(4):322-337. PubMed ID: 29231933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands.
    Kong Y; Chen F; Su Z; Qian Y; Wang FX; Wang X; Zhao J; Mao ZW; Liu HK
    J Inorg Biochem; 2018 May; 182():194-199. PubMed ID: 29501980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photocytotoxic activity of a nitrosyl phthalocyanine ruthenium complex--a system capable of producing nitric oxide and singlet oxygen.
    Carneiro ZA; de Moraes JC; Rodrigues FP; de Lima RG; Curti C; da Rocha ZN; Paulo M; Bendhack LM; Tedesco AC; Formiga AL; da Silva RS
    J Inorg Biochem; 2011 Aug; 105(8):1035-43. PubMed ID: 21726765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed-ligand complexes of ruthenium(II) containing new photoactive or electroactive ligands: synthesis, spectral characterization and DNA interactions.
    Ghosh T; Maiya BG; Samanta A; Shukla AD; Jose DA; Kumar DK; Das A
    J Biol Inorg Chem; 2005 Aug; 10(5):496-508. PubMed ID: 15981005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis, and Antibacterial Activity of a Multivalent Polycationic Calix[4]arene-NO Photodonor Conjugate.
    Consoli GML; Di Bari I; Blanco AR; Nostro A; D'Arrigo M; Pistarà V; Sortino S
    ACS Med Chem Lett; 2017 Aug; 8(8):881-885. PubMed ID: 28835806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents.
    Biancalana L; Pampaloni G; Marchetti F
    Chimia (Aarau); 2017 Sep; 71(9):573-579. PubMed ID: 30188287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.
    Thangavel P; Viswanath B; Kim S
    Int J Nanomedicine; 2017; 12():2749-2758. PubMed ID: 28435255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipophilicity-antiproliferative activity relationship study leads to the preparation of a ruthenium(II) arene complex with considerable in vitro cytotoxicity against cancer cells and a lower in vivo toxicity in zebrafish embryos than clinically approved cis-platin.
    Haghdoost M; Golbaghi G; Létourneau M; Patten SA; Castonguay A
    Eur J Med Chem; 2017 May; 132():282-293. PubMed ID: 28371640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Versatile Impact of Serum Proteins on Ruthenium(II) Polypyridyl Complexes Properties - Opportunities and Obstacles.
    Mazuryk O; Gajda-Morszewski P; Brindell M
    Curr Protein Pept Sci; 2019; 20(11):1052-1059. PubMed ID: 31092177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.